New COPD drug shows promise in Real-World romanian study

NCT ID NCT06368427

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 10 people with moderate to severe COPD in Romania who started taking the inhaler TRIXEO AEROSPHERE. Researchers measured changes in their health status and treatment satisfaction over 3 and 6 months. The goal was to see how the medication works in everyday life, not in a controlled lab setting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Baia Mare, Romania

  • Research Site

    Bucharest, Romania

  • Research Site

    Cluj-Napoca, Romania

  • Research Site

    Constanța, Romania

  • Research Site

    Craiova, Romania

  • Research Site

    Deva, Romania

  • Research Site

    Dorohoi, Romania

  • Research Site

    Hunedoara, Romania

  • Research Site

    Iași, Romania

  • Research Site

    Luduş, Romania

  • Research Site

    Medgidia, Romania

  • Research Site

    Oradea, Romania

  • Research Site

    Sighișoara, Romania

  • Research Site

    Suceava, Romania

  • Research Site

    Târgu Mureş, Romania

  • Research Site

    Timișoara, Romania